Atossa Genetics Inc. (ATOS) Social Stream



Atossa Genetics Inc. (ATOS): $1.01

-0.08 (-7.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ATOS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

Featured Post From StockTwits About ATOS

$ATOS - Atossa Therapeutics DD , updates on their AT-301 / AT-H201 COVID and Endoxifen breast cancer treatments.

It’s time to discuss Atossa Therapeutics again without so much negativity. I know there was the nonsense about a short squeeze/gamma squeeze, but this is a longer term hold. Now that the dust has settled, I am revisiting this play. Especially now with all the variants this could be a covid play as well...

New Positions Reported:

Group One Trade – 1,644,488 Shares

Nuveen Asset Management, - 1,097,131 Shares

Millennium Management 1,666,911 Shares

Bank of Nova Scotia – 348,698 Shares

Increased Positions Reported:

Northern Trust Corp - 1,1231,852 Shares

Vanguard Group Inc – 5,762,626 Shares

Geode Capital Management – 1,968,745 Shares

BlackRock Inc – 8.954,293 Shares

Bank of New York Mellon Corp – 465,572 Shares

Let’s talk about the timeline on Phase 3 for Endoxifen. FDA 505(b)(2) may bring Endoxifen to market without the need of Phase 3.

https://www.reddit.com/r/pennystocks/comments/p5s2pq/atossa_therapeutics_dd_updates_on_their_at301/
rigpig, published August 17, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4291 seconds.